mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy

Yan Zheng(Jinzhou Medical University), Yijie Shi(Jinzhou Medical University)

Journal of Nanobiotechnology

October 4, 2017

10.1186/s12951-017-0302-5

Cited by 21

Related Papers

Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting the delivery of quercetin towards impaired neurons

|Journal of Nanobiotechnology|2021|119